252 related articles for article (PubMed ID: 21966433)
1. Partial inhibition of estrogen-induced mammary carcinogenesis in rats by tamoxifen: balance between oxidant stress and estrogen responsiveness.
Singh B; Bhat NK; Bhat HK
PLoS One; 2011; 6(9):e25125. PubMed ID: 21966433
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant butylated hydroxyanisole inhibits estrogen-induced breast carcinogenesis in female ACI rats.
Singh B; Mense SM; Remotti F; Liu X; Bhat HK
J Biochem Mol Toxicol; 2009; 23(3):202-11. PubMed ID: 19526586
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure.
Mense SM; Remotti F; Bhan A; Singh B; El-Tamer M; Hei TK; Bhat HK
Toxicol Appl Pharmacol; 2008 Oct; 232(1):78-85. PubMed ID: 18640140
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer.
Singh B; Chatterjee A; Ronghe AM; Bhat NK; Bhat HK
BMC Cancer; 2013 May; 13():253. PubMed ID: 23697596
[TBL] [Abstract][Full Text] [Related]
5. Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats.
Mense SM; Singh B; Remotti F; Liu X; Bhat HK
Carcinogenesis; 2009 Jul; 30(7):1202-8. PubMed ID: 19406931
[TBL] [Abstract][Full Text] [Related]
6. Superoxide dismutase 3 is induced by antioxidants, inhibits oxidative DNA damage and is associated with inhibition of estrogen-induced breast cancer.
Singh B; Bhat HK
Carcinogenesis; 2012 Dec; 33(12):2601-10. PubMed ID: 23027624
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer.
Mobley JA; Brueggemeier RW
Carcinogenesis; 2004 Jan; 25(1):3-9. PubMed ID: 14514655
[TBL] [Abstract][Full Text] [Related]
8. Effect of vitamin C on lipidperoxidation and antioxidant status in tamoxifen-treated breast cancer patients.
Muralikrishnan G; Amanullah S; Basha MI; Boopalan S; Vijayakumar S; Shakeel F
Chemotherapy; 2010; 56(4):298-302. PubMed ID: 20714147
[TBL] [Abstract][Full Text] [Related]
9. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
10. Protective roles of quinone reductase and tamoxifen against estrogen-induced mammary tumorigenesis.
Montano MM; Chaplin LJ; Deng H; Mesia-Vela S; Gaikwad N; Zahid M; Rogan E
Oncogene; 2007 May; 26(24):3587-90. PubMed ID: 17160017
[TBL] [Abstract][Full Text] [Related]
11. L-selenomethionine does not protect against testosterone plus 17β-estradiol-induced oxidative stress and preneoplastic lesions in the prostate of NBL rats.
Özten N; Schlicht M; Diamond AM; Bosland MC
Nutr Cancer; 2014; 66(5):825-34. PubMed ID: 24773027
[TBL] [Abstract][Full Text] [Related]
12. Tocopherols inhibit oxidative and nitrosative stress in estrogen-induced early mammary hyperplasia in ACI rats.
Das Gupta S; So JY; Wall B; Wahler J; Smolarek AK; Sae-Tan S; Soewono KY; Yu H; Lee MJ; Thomas PE; Yang CS; Suh N
Mol Carcinog; 2015 Sep; 54(9):916-25. PubMed ID: 24782330
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways.
Singh B; Shoulson R; Chatterjee A; Ronghe A; Bhat NK; Dim DC; Bhat HK
Carcinogenesis; 2014 Aug; 35(8):1872-80. PubMed ID: 24894866
[TBL] [Abstract][Full Text] [Related]
14. Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer.
Singh B; Bhat NK; Bhat HK
Carcinogenesis; 2012 Jan; 33(1):156-63. PubMed ID: 22072621
[TBL] [Abstract][Full Text] [Related]
15. Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats.
Singh B; Mense SM; Bhat NK; Putty S; Guthiel WA; Remotti F; Bhat HK
Toxicol Appl Pharmacol; 2010 Sep; 247(2):83-90. PubMed ID: 20600213
[TBL] [Abstract][Full Text] [Related]
16. Differential oxidant potential of carcinogenic and weakly carcinogenic estrogens: Involvement of metabolic activation and cytochrome P450.
Patel MM; Bhat HK
J Biochem Mol Toxicol; 2004; 18(1):37-42. PubMed ID: 14994278
[TBL] [Abstract][Full Text] [Related]
17. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
18. The effect of flutamide and tamoxifen on sex hormone-induced mammary carcinogenesis and pituitary adenoma.
Leung G; Tsao SW; Wong YC
Breast Cancer Res Treat; 2002 Mar; 72(2):153-62. PubMed ID: 12038706
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the Effects of Octreotide Agent on Oxidative Stress, 8-Hydroxy Deoxyguanosine in Experimental Hepatic Carcinogenesis Rat Model.
Unsal V; Kurutaş EB
Folia Med (Plovdiv); 2020 Mar; 62(1):70-75. PubMed ID: 32337899
[TBL] [Abstract][Full Text] [Related]
20. Increased 8-hydroxy-2'-deoxyguanosine in plasma and decreased mRNA expression of human 8-oxoguanine DNA glycosylase 1, anti-oxidant enzymes, mitochondrial biogenesis-related proteins and glycolytic enzymes in leucocytes in patients with systemic lupus erythematosus.
Lee HT; Lin CS; Lee CS; Tsai CY; Wei YH
Clin Exp Immunol; 2014 Apr; 176(1):66-77. PubMed ID: 24345202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
